Soliton and Resonic

AbbVie makes a hefty play to boost aesthetics business, paying $550M for non-invasive body sculpting device
Endpoints
Mon, 05/10/21 - 09:37 am
AbbVie
Allergan Aesthetics
M&A
Soliton and Resonic